Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
0JQ2.L
$0.4185
$
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Next Earnings
2026-02-25
Beta
-2.442
Average Volume
Market Cap
Last Dividend
CIK
ISIN
US4831192020
CUSIP
483119202
CEO
R. Kim Brazzell
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Full Time Employees
38
IPO Date
2018-01-29
Status
Active
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|